3 Common Clinical Trial Patient Recruitment Challenges and Their...

Pharma Tech Outlook: Pharma Tech Magazine

3 Common Clinical Trial Patient Recruitment Challenges and Their Solutions

Stacey Smith, Pharma Tech Outlook | Thursday, January 13, 2022

Effective patient recruitment is a key determinant of success for clinical trials.

FREMONT, CA: According to a recent report, more than 80% of clinical trials in the United States fail to meet their patient recruitment timelines. This delays increase costs, overuse resources, and prolong the time to market. Patient recruitment is daunting as it involves multiple stakeholders, like patients, healthcare providers, office staff, sponsors, and clinical trial research teams. A lot can go wrong in-patient recruitment, leading to delays for up to 80% of all clinical trials. Here are some of the most common challenges and their solutions.

Top 10 eClinical Trial Management Solution Companies - 2020• Underperforming Research Sites

Clinical trial recruitment rarely takes challenges at the site level into account. Even with an effective site selection process, unforeseen issues at sites can slow recruitment. Competition from other trial sites can also make a negative impact on site performance. It's important to diversify the approach to patient recruitment early on in the process. Identifying clinical trial patient recruitment companies to work with, and engaging them for digital advertising or partnership opportunities before sites begin underperforming can create positive impacts. Having a diverse approach from the beginning allows trial teams to beat their timelines.

• Identifying Patient with Complex Eligibility

Clinical trials are increasing in complexity. Researchers may look for patients with specific lab values. This means that research sites screen fail more patients, leading to delays in recruitment. To speed the process of identifying patients with complex eligibility, research firms should consider working with a patient recruitment firm that has additional layers of data. Knowing the medication patients are taking, or the results from recent blood work can make it easier to connect with the right patients.

• Reaching Out to Potentially Interested Subjects

Even if a subject is interested in taking part in the trial, there are still possibilities to lose contact in the course of their journey from learning about the trial to randomizing. Patients may miss the message or be unable to attend a site visit for additional screening. So, reaching out to potentially interested patients and conducting site screening can be challenging for staff, and they may miss following up with patients. Working with a recruitment agency that offers site and patient follow-up services can help researchers successfully progress interesting subjects to the next step. Automated follow-ups can also give patients multiple opportunities to set up a site visit.

See Also: Top Healthcare Solution Companies

Weekly Brief

Read Also